These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 31880685)
21. Severe vision loss caused by cosmetic filler augmentation: Case series with review of cause and therapy. Thanasarnaksorn W; Cotofana S; Rudolph C; Kraisak P; Chanasumon N; Suwanchinda A J Cosmet Dermatol; 2018 Oct; 17(5):712-718. PubMed ID: 30006992 [TBL] [Abstract][Full Text] [Related]
22. Prevention and Management of Filler Induced Iatrogenic Stroke of the Eye [Formula: see text]. Arlette JP; Ashenhurst M; Hill V; Jiang K J Cutan Med Surg; 2021 Sep; 25(5):543-552. PubMed ID: 33653128 [TBL] [Abstract][Full Text] [Related]
23. Vision Loss Associated with Hyaluronic Acid Fillers: A Systematic Review of Literature. Kapoor KM; Kapoor P; Heydenrych I; Bertossi D Aesthetic Plast Surg; 2020 Jun; 44(3):929-944. PubMed ID: 31822960 [TBL] [Abstract][Full Text] [Related]
24. Update on Emergency and Nonemergency Use of Hyaluronidase in Aesthetic Dermatology. Jones DH JAMA Dermatol; 2018 Jul; 154(7):763-764. PubMed ID: 29710242 [No Abstract] [Full Text] [Related]
25. Long-term Prognosis of Vision Loss Caused by Facial Hyaluronic Acid Injections and the Potential Approaches to Address This Catastrophic Event. Zhang L; Zhou Q; Xu H; Gu Q; Shi H; Pan L; Sun Y; Wu S Aesthet Surg J; 2023 Mar; 43(4):484-493. PubMed ID: 36495213 [TBL] [Abstract][Full Text] [Related]
26. Iatrogenic vision loss following aesthetic treatment with hyaluronic acid-containing filler: Every injector should be prepared. Thulesen J Dermatol Ther; 2020 Nov; 33(6):e13913. PubMed ID: 32594559 [TBL] [Abstract][Full Text] [Related]
27. Blindness After Filler Injection: Mechanism and Treatment. Hwang CJ; Chon BH; Perry JD Facial Plast Surg Clin North Am; 2021 May; 29(2):359-367. PubMed ID: 33906767 [TBL] [Abstract][Full Text] [Related]
28. Commentary on: Efficacy of Retrobulbar Hyaluronidase Injection for Vision Loss Resulting from Hyaluronic Acid Filler Embolization. DeLorenzi C Aesthet Surg J; 2017 Dec; 38(1):23-27. PubMed ID: 29244093 [No Abstract] [Full Text] [Related]
29. Commentary on Restoration of Visual Loss With Retrobulbar Hyaluronidase Injection After Hyaluronic Acid Filler. Fagien S; Carruthers J Dermatol Surg; 2018 Mar; 44(3):437-443. PubMed ID: 29517498 [No Abstract] [Full Text] [Related]
30. Effectiveness of Retrobulbar Hyaluronidase Injection in an Iatrogenic Blindness Rabbit Model Using Hyaluronic Acid Filler Injection. Hwang CJ; Perry JD Plast Reconstr Surg; 2020 Mar; 145(3):658e-660e. PubMed ID: 32097351 [No Abstract] [Full Text] [Related]
31. Reply: Effectiveness of Retrobulbar Hyaluronidase Injection in an Iatrogenic Blindness Rabbit Model Using Hyaluronic Acid Filler Injection. Lee W; Yang EJ Plast Reconstr Surg; 2020 Mar; 145(3):659e-661e. PubMed ID: 32097352 [No Abstract] [Full Text] [Related]
32. Discussion: Effectiveness of Retrobulbar Hyaluronidase Injection in an Iatrogenic Blindness Rabbit Model Using Hyaluronic Acid Filler Injection. Fagien S Plast Reconstr Surg; 2019 Jul; 144(1):144-146. PubMed ID: 31246818 [No Abstract] [Full Text] [Related]
33. Reply re: "Commentary on: 'Examining the Role of Retrobulbar Hyaluronidase in Reversing Filler Induced Blindness: A Systemic Review,' by Paap MK, Milman T, Ugradar S, Goldberg R, Silkiss RZ". Silkiss RZ; Paap MK Ophthalmic Plast Reconstr Surg; 2020; 36(5):522-523. PubMed ID: 32925678 [No Abstract] [Full Text] [Related]